Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 70 entries
Sorted by: Best Match Show Resources per page
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.

Breast care (Basel, Switzerland)

Jackisch C, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, Marschner N, Möbus V, Scheithauer H, Schneeweiss A, Thomssen C, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Fasching PA, Fehm T, Janni W, Lück HJ, Maass N, Scharl A, Untch M.
PMID: 26557827
Breast Care (Basel). 2015 Jul;10(3):211-9. doi: 10.1159/000433590. Epub 2015 Jun 23.

The key topics of this year's 14th St. Gallen Consensus Conference on the diagnosis and therapy of primary breast cancer were again questions about breast surgery and axillary surgery, radio-oncology and systemic therapy options in consideration of tumor biology,...

Cite
Jackisch C, Harbeck N, Huober J, et al. 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast Care (Basel). 2015;10(3):211-9doi: 10.1159/000433590.
Jackisch, C., Harbeck, N., Huober, J., von Minckwitz, G., Gerber, B., Kreipe, H. H., Liedtke, C., Marschner, N., Möbus, V., Scheithauer, H., Schneeweiss, A., Thomssen, C., Loibl, S., Beckmann, M. W., Blohmer, J. U., Costa, S. D., Decker, T., Diel, I., Fasching, P. A., Fehm, T., Janni, W., Lück, H. J., Maass, N., Scharl, A., & Untch, M. (2015). 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast care (Basel, Switzerland), 10(3), 211-9. https://doi.org/10.1159/000433590
Jackisch, Christian, et al. "14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts." Breast care (Basel, Switzerland) vol. 10,3 (2015): 211-9. doi: https://doi.org/10.1159/000433590
Jackisch C, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, Marschner N, Möbus V, Scheithauer H, Schneeweiss A, Thomssen C, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Fasching PA, Fehm T, Janni W, Lück HJ, Maass N, Scharl A, Untch M. 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast Care (Basel). 2015 Jul;10(3):211-9. doi: 10.1159/000433590. Epub 2015 Jun 23. PMID: 26557827; PMCID: PMC4569213.
Copy Download .nbib Format: NLM
Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC.

Breast care (Basel, Switzerland)

Kümmel A, Kümmel S, Blohmer JU, Faridi A, Nitz U, Loibl S, von Fritschen U, Rezek D, Hagemann F, Holtschmidt J, Botzenhardt S, Reinisch M.
PMID: 31316315
Breast Care (Basel). 2019 Jun;14(3):165-169. doi: 10.1159/000490040. Epub 2018 Nov 14.

BACKGROUND: Autologous fat transfer in breast reconstruction has become increasingly important in breast reconstructive surgery. Although the indication to obtain fat, the various operative procedures, and the risks for the patient have been addressed in a large number of...

Cite
Kümmel A, Kümmel S, Blohmer JU, et al. Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC. Breast Care (Basel). 2018;14(3):165-169doi: 10.1159/000490040.
Kümmel, A., Kümmel, S., Blohmer, J. U., Faridi, A., Nitz, U., Loibl, S., von Fritschen, U., Rezek, D., Hagemann, F., Holtschmidt, J., Botzenhardt, S., & Reinisch, M. (2019). Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC. Breast care (Basel, Switzerland), 14(3), 165-169. https://doi.org/10.1159/000490040
Kümmel, Aylin, et al. "Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC." Breast care (Basel, Switzerland) vol. 14,3 (2019): 165-169. doi: https://doi.org/10.1159/000490040
Kümmel A, Kümmel S, Blohmer JU, Faridi A, Nitz U, Loibl S, von Fritschen U, Rezek D, Hagemann F, Holtschmidt J, Botzenhardt S, Reinisch M. Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC. Breast Care (Basel). 2019 Jun;14(3):165-169. doi: 10.1159/000490040. Epub 2018 Nov 14. PMID: 31316315; PMCID: PMC6600037.
Copy Download .nbib Format: NLM
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.

Geburtshilfe und Frauenheilkunde

Wöckel A, Festl J, Stüber T, Brust K, Krockenberger M, Heuschmann PU, Jírů-Hillmann S, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kühn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, König K, Hahne A, Baumgartner T, Kreipe HH, Knoefel WT, Denkinger M, Brucker S, Lüftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Müller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Hölzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmüller S, Sinn HP, Dunst J, Münstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching P, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Köbrunner S, Huober J, Hübner J, Jackisch C, Loibl S, Lück HJ, von Minckwitz G, Möbus V, Müller V, Nöthlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schütz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bücker A, Buck A, Stangl S.
PMID: 30581198
Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1056-1088. doi: 10.1055/a-0646-4630. Epub 2018 Nov 26.

No abstract available.

Cite
Wöckel A, Festl J, Stüber T, et al. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer. Geburtshilfe Frauenheilkd. 2018;78(11):1056-1088doi: 10.1055/a-0646-4630.
Wöckel, A., Festl, J., Stüber, T., Brust, K., Krockenberger, M., Heuschmann, P. U., Jírů-Hillmann, S., Albert, U. S., Budach, W., Follmann, M., Janni, W., Kopp, I., Kreienberg, R., Kühn, T., Langer, T., Nothacker, M., Scharl, A., Schreer, I., Link, H., Engel, J., Fehm, T., Weis, J., Welt, A., Steckelberg, A., Feyer, P., König, K., Hahne, A., Baumgartner, T., Kreipe, H. H., Knoefel, W. T., Denkinger, M., Brucker, S., Lüftner, D., Kubisch, C., Gerlach, C., Lebeau, A., Siedentopf, F., Petersen, C., Bartsch, H. H., Schulz-Wendtland, R., Hahn, M., Hanf, V., Müller-Schimpfle, M., Henscher, U., Roncarati, R., Katalinic, A., Heitmann, C., Honegger, C., Paradies, K., Bjelic-Radisic, V., Degenhardt, F., Wenz, F., Rick, O., Hölzel, D., Zaiss, M., Kemper, G., Budach, V., Denkert, C., Gerber, B., Tesch, H., Hirsmüller, S., Sinn, H. P., Dunst, J., Münstedt, K., Bick, U., Fallenberg, E., Tholen, R., Hung, R., Baumann, F., Beckmann, M. W., Blohmer, J., Fasching, P., Lux, M. P., Harbeck, N., Hadji, P., Hauner, H., Heywang-Köbrunner, S., Huober, J., Hübner, J., Jackisch, C., Loibl, S., Lück, H. J., von Minckwitz, G., Möbus, V., Müller, V., Nöthlings, U., Schmidt, M., Schmutzler, R., Schneeweiss, A., Schütz, F., Stickeler, E., Thomssen, C., Untch, M., Wesselmann, S., Bücker, A., Buck, A., & Stangl, S. (2018). Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer. Geburtshilfe und Frauenheilkunde, 78(11), 1056-1088. https://doi.org/10.1055/a-0646-4630
Wöckel, Achim, et al. "Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer." Geburtshilfe und Frauenheilkunde vol. 78,11 (2018): 1056-1088. doi: https://doi.org/10.1055/a-0646-4630
Wöckel A, Festl J, Stüber T, Brust K, Krockenberger M, Heuschmann PU, Jírů-Hillmann S, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kühn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, König K, Hahne A, Baumgartner T, Kreipe HH, Knoefel WT, Denkinger M, Brucker S, Lüftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Müller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Hölzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmüller S, Sinn HP, Dunst J, Münstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching P, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Köbrunner S, Huober J, Hübner J, Jackisch C, Loibl S, Lück HJ, von Minckwitz G, Möbus V, Müller V, Nöthlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schütz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bücker A, Buck A, Stangl S. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer. Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1056-1088. doi: 10.1055/a-0646-4630. Epub 2018 Nov 26. PMID: 30581198; PMCID: PMC6261741.
Copy Download .nbib Format: NLM
Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity.

Heliyon

Bhattacharya D, Fujihashi A, Majrashi M, Bloemer J, Bhattacharya S, Buabeid M, Escobar M, Moore T, Suppiramaniam V, Dhanasekaran M.
PMID: 31938742
Heliyon. 2020 Jan 08;6(1):e03045. doi: 10.1016/j.heliyon.2019.e03045. eCollection 2020 Jan.

AIMS: This study investigated the neurotoxic effects of prenatal alcohol and nicotine exposure in the cortex and hippocampus of rodents.MAIN METHODS: Behavioral alterations, electrophysiological changes, and biochemical markers associated with cholinergic neurotransmission, neural oxidative stress, mitochondrial function, and apoptosis...

Cite
Bhattacharya D, Fujihashi A, Majrashi M, et al. Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity. Heliyon. 2020;6(1):e03045doi: 10.1016/j.heliyon.2019.e03045.
Bhattacharya, D., Fujihashi, A., Majrashi, M., Bloemer, J., Bhattacharya, S., Buabeid, M., Escobar, M., Moore, T., Suppiramaniam, V., & Dhanasekaran, M. (2020). Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity. Heliyon, 6(1), e03045. https://doi.org/10.1016/j.heliyon.2019.e03045
Bhattacharya, Dwipayan, et al. "Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity." Heliyon vol. 6,1 (2020): e03045. doi: https://doi.org/10.1016/j.heliyon.2019.e03045
Bhattacharya D, Fujihashi A, Majrashi M, Bloemer J, Bhattacharya S, Buabeid M, Escobar M, Moore T, Suppiramaniam V, Dhanasekaran M. Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity. Heliyon. 2020 Jan 08;6(1):e03045. doi: 10.1016/j.heliyon.2019.e03045. eCollection 2020 Jan. PMID: 31938742; PMCID: PMC6953639.
Copy Download .nbib Format: NLM
ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.

Annals of surgical oncology

Fitzal F, Bolliger M, Dunkler D, Geroldinger A, Gambone L, Heil J, Riedel F, de Boniface J, Andre C, Matrai Z, Pukancsik D, Paulinelli RR, Ostapenko V, Burneckis A, Ostapenko A, Ostapenko E, Meani F, Harder Y, Bonollo M, Alberti ASM, Tausch C, Papassotiropoulos B, Helfgott R, Heck D, Fehrer HJ, Acko M, Schrenk P, Trapp E, Gunda P, Clara P, Montagna G, Ritter M, Blohmer JU, Steffen S, Romics L, Morrow E, Lorenz K, Fehr M, Weber WP.
PMID: 34676460
Ann Surg Oncol. 2022 Feb;29(2):1073-1075. doi: 10.1245/s10434-021-10898-y.

No abstract available.

Cite
Fitzal F, Bolliger M, Dunkler D, et al. ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study. Ann Surg Oncol. 2022;29(2):1073-1075doi: 10.1245/s10434-021-10898-y.
Fitzal, F., Bolliger, M., Dunkler, D., Geroldinger, A., Gambone, L., Heil, J., Riedel, F., de Boniface, J., Andre, C., Matrai, Z., Pukancsik, D., Paulinelli, R. R., Ostapenko, V., Burneckis, A., Ostapenko, A., Ostapenko, E., Meani, F., Harder, Y., Bonollo, M., Alberti, A. S. M., Tausch, C., Papassotiropoulos, B., Helfgott, R., Heck, D., Fehrer, H. J., Acko, M., Schrenk, P., Trapp, E., Gunda, P., Clara, P., Montagna, G., Ritter, M., Blohmer, J. U., Steffen, S., Romics, L., Morrow, E., Lorenz, K., Fehr, M., & Weber, W. P. (2022). ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study. Annals of surgical oncology, 29(2), 1073-1075. https://doi.org/10.1245/s10434-021-10898-y
Fitzal, Florian, et al. "ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study." Annals of surgical oncology vol. 29,2 (2022): 1073-1075. doi: https://doi.org/10.1245/s10434-021-10898-y
Fitzal F, Bolliger M, Dunkler D, Geroldinger A, Gambone L, Heil J, Riedel F, de Boniface J, Andre C, Matrai Z, Pukancsik D, Paulinelli RR, Ostapenko V, Burneckis A, Ostapenko A, Ostapenko E, Meani F, Harder Y, Bonollo M, Alberti ASM, Tausch C, Papassotiropoulos B, Helfgott R, Heck D, Fehrer HJ, Acko M, Schrenk P, Trapp E, Gunda P, Clara P, Montagna G, Ritter M, Blohmer JU, Steffen S, Romics L, Morrow E, Lorenz K, Fehr M, Weber WP. ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study. Ann Surg Oncol. 2022 Feb;29(2):1073-1075. doi: 10.1245/s10434-021-10898-y. PMID: 34676460.
Copy Download .nbib Format: NLM
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial.

JAMA oncology

Friedl TWP, Fehm T, Müller V, Lichtenegger W, Blohmer J, Lorenz R, Forstbauer H, Fink V, Bekes I, Huober J, Jückstock J, Schneeweiss A, Tesch H, Mahner S, Brucker SY, Heinrich G, Häberle L, Fasching PA, Beckmann MW, Coleman RE, Janni W, Rack B.
PMID: 34165508
JAMA Oncol. 2021 Aug 01;7(8):1149-1157. doi: 10.1001/jamaoncol.2021.1854.

IMPORTANCE: Bisphosphonate treatment in patients with early breast cancer has become part of care, but the optimal treatment duration is still unclear.OBJECTIVE: To compare 2 vs 5 years of zoledronate treatment following adjuvant chemotherapy in patients with early breast...

Cite
Friedl TWP, Fehm T, Müller V, et al. Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2021;7(8):1149-1157doi: 10.1001/jamaoncol.2021.1854.
Friedl, T. W. P., Fehm, T., Müller, V., Lichtenegger, W., Blohmer, J., Lorenz, R., Forstbauer, H., Fink, V., Bekes, I., Huober, J., Jückstock, J., Schneeweiss, A., Tesch, H., Mahner, S., Brucker, S. Y., Heinrich, G., Häberle, L., Fasching, P. A., Beckmann, M. W., Coleman, R. E., Janni, W., & Rack, B. (2021). Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial. JAMA oncology, 7(8), 1149-1157. https://doi.org/10.1001/jamaoncol.2021.1854
Friedl, Thomas W P, et al. "Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial." JAMA oncology vol. 7,8 (2021): 1149-1157. doi: https://doi.org/10.1001/jamaoncol.2021.1854
Friedl TWP, Fehm T, Müller V, Lichtenegger W, Blohmer J, Lorenz R, Forstbauer H, Fink V, Bekes I, Huober J, Jückstock J, Schneeweiss A, Tesch H, Mahner S, Brucker SY, Heinrich G, Häberle L, Fasching PA, Beckmann MW, Coleman RE, Janni W, Rack B. Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2021 Aug 01;7(8):1149-1157. doi: 10.1001/jamaoncol.2021.1854. PMID: 34165508; PMCID: PMC8227465.
Copy Download .nbib Format: NLM
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.

Cancers

Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M, Paluchowski P, Solbach C, Blohmer JU, Kühn T, The Axsana Study Group.
PMID: 33805367
Cancers (Basel). 2021 Mar 29;13(7). doi: 10.3390/cancers13071565.

In the last two decades, surgical methods for axillary staging in breast cancer patients have become less extensive, and full axillary lymph node dissection (ALND) is confined to selected patients. In initially node-positive patients undergoing neoadjuvant chemotherapy, however, the...

Cite
Banys-Paluchowski M, Gasparri ML, de Boniface J, et al. Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study. Cancers (Basel). 2021;13(7)doi: 10.3390/cancers13071565.
Banys-Paluchowski, M., Gasparri, M. L., de Boniface, J., Gentilini, O., Stickeler, E., Hartmann, S., Thill, M., Rubio, I. T., Di Micco, R., Bonci, E. A., Niinikoski, L., Kontos, M., Karadeniz Cakmak, G., Hauptmann, M., Peintinger, F., Pinto, D., Matrai, Z., Murawa, D., Kadayaprath, G., Dostalek, L., Nina, H., Krivorotko, P., Classe, J. M., Schlichting, E., Appelgren, M., Paluchowski, P., Solbach, C., Blohmer, J. U., Kühn, T., & The Axsana Study Group. (2021). Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study. Cancers, 13(7), . https://doi.org/10.3390/cancers13071565
Banys-Paluchowski, Maggie, et al. "Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study." Cancers vol. 13,7 (2021). doi: https://doi.org/10.3390/cancers13071565
Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M, Paluchowski P, Solbach C, Blohmer JU, Kühn T, The Axsana Study Group. Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study. Cancers (Basel). 2021 Mar 29;13(7). doi: 10.3390/cancers13071565. PMID: 33805367; PMCID: PMC8037995.
Copy Download .nbib Format: NLM
Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress.

Frontiers in molecular neuroscience

Govindarajulu M, Pinky PD, Steinke I, Bloemer J, Ramesh S, Kariharan T, Rella RT, Bhattacharya S, Dhanasekaran M, Suppiramaniam V, Amin RH.
PMID: 32903435
Front Mol Neurosci. 2020 Aug 12;13:138. doi: 10.3389/fnmol.2020.00138. eCollection 2020.

Dysbiosis of gut microbiota is strongly associated with metabolic diseases including diabetes mellitus, obesity, and cardiovascular disease. Recent studies indicate that Trimethylamine N-oxide (TMAO), a gut microbe-dependent metabolite is implicated in the development of age-related cognitive decline. However, the...

Cite
Govindarajulu M, Pinky PD, Steinke I, et al. Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress. Front Mol Neurosci. 2020;13:138doi: 10.3389/fnmol.2020.00138.
Govindarajulu, M., Pinky, P. D., Steinke, I., Bloemer, J., Ramesh, S., Kariharan, T., Rella, R. T., Bhattacharya, S., Dhanasekaran, M., Suppiramaniam, V., & Amin, R. H. (2020). Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress. Frontiers in molecular neuroscience, 13138. https://doi.org/10.3389/fnmol.2020.00138
Govindarajulu, Manoj, et al. "Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress." Frontiers in molecular neuroscience vol. 13 (2020): 138. doi: https://doi.org/10.3389/fnmol.2020.00138
Govindarajulu M, Pinky PD, Steinke I, Bloemer J, Ramesh S, Kariharan T, Rella RT, Bhattacharya S, Dhanasekaran M, Suppiramaniam V, Amin RH. Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress. Front Mol Neurosci. 2020 Aug 12;13:138. doi: 10.3389/fnmol.2020.00138. eCollection 2020. PMID: 32903435; PMCID: PMC7437142.
Copy Download .nbib Format: NLM
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.

British journal of cancer

Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S, Alvarado M, Douek M, Saunders C, Flyger H, Eiermann W, Brew-Graves C, Williams NR, Potyka I, Roberts N, Bernstein M, Brown D, Sperk E, Laws S, Sütterlin M, Corica T, Lundgren S, Holmes D, Vinante L, Bozza F, Pazos M, Blanc-Onfroy ML, Gruber G, Polkowski W, Dedes KJ, Niewald M, Blohmer J, McReady D, Hoefer R, Kelemen P, Petralia G, Falzon M, Joseph D, Tobias JS.
PMID: 34035435
Br J Cancer. 2021 Aug;125(3):380-389. doi: 10.1038/s41416-021-01440-8. Epub 2021 May 25.

BACKGROUND: The TARGIT-A trial reported risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer to be as effective as whole-breast external beam radiotherapy (EBRT). Here, we present further detailed analyses.METHODS: In total, 2298 women (≥45 years, invasive ductal...

Cite
Vaidya JS, Bulsara M, Baum M, et al. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer. Br J Cancer. 2021;125(3):380-389doi: 10.1038/s41416-021-01440-8.
Vaidya, J. S., Bulsara, M., Baum, M., Wenz, F., Massarut, S., Pigorsch, S., Alvarado, M., Douek, M., Saunders, C., Flyger, H., Eiermann, W., Brew-Graves, C., Williams, N. R., Potyka, I., Roberts, N., Bernstein, M., Brown, D., Sperk, E., Laws, S., Sütterlin, M., Corica, T., Lundgren, S., Holmes, D., Vinante, L., Bozza, F., Pazos, M., Blanc-Onfroy, M. L., Gruber, G., Polkowski, W., Dedes, K. J., Niewald, M., Blohmer, J., McReady, D., Hoefer, R., Kelemen, P., Petralia, G., Falzon, M., Joseph, D., & Tobias, J. S. (2021). New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer. British journal of cancer, 125(3), 380-389. https://doi.org/10.1038/s41416-021-01440-8
Vaidya, Jayant S, et al. "New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer." British journal of cancer vol. 125,3 (2021): 380-389. doi: https://doi.org/10.1038/s41416-021-01440-8
Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S, Alvarado M, Douek M, Saunders C, Flyger H, Eiermann W, Brew-Graves C, Williams NR, Potyka I, Roberts N, Bernstein M, Brown D, Sperk E, Laws S, Sütterlin M, Corica T, Lundgren S, Holmes D, Vinante L, Bozza F, Pazos M, Blanc-Onfroy ML, Gruber G, Polkowski W, Dedes KJ, Niewald M, Blohmer J, McReady D, Hoefer R, Kelemen P, Petralia G, Falzon M, Joseph D, Tobias JS. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer. Br J Cancer. 2021 Aug;125(3):380-389. doi: 10.1038/s41416-021-01440-8. Epub 2021 May 25. PMID: 34035435; PMCID: PMC8329051.
Copy Download .nbib Format: NLM
Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring.

Heliyon

Pinky PD, Majrashi M, Fujihashi A, Bloemer J, Govindarajulu M, Ramesh S, Reed MN, Moore T, Suppiramaniam V, Dhanasekaran M.
PMID: 33912711
Heliyon. 2021 Apr 13;7(4):e06730. doi: 10.1016/j.heliyon.2021.e06730. eCollection 2021 Apr.

No abstract available.

Cite
Pinky PD, Majrashi M, Fujihashi A, et al. Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring. Heliyon. 2021;7(4):e06730doi: 10.1016/j.heliyon.2021.e06730.
Pinky, P. D., Majrashi, M., Fujihashi, A., Bloemer, J., Govindarajulu, M., Ramesh, S., Reed, M. N., Moore, T., Suppiramaniam, V., & Dhanasekaran, M. (2021). Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring. Heliyon, 7(4), e06730. https://doi.org/10.1016/j.heliyon.2021.e06730
Pinky, Priyanka D, et al. "Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring." Heliyon vol. 7,4 (2021): e06730. doi: https://doi.org/10.1016/j.heliyon.2021.e06730
Pinky PD, Majrashi M, Fujihashi A, Bloemer J, Govindarajulu M, Ramesh S, Reed MN, Moore T, Suppiramaniam V, Dhanasekaran M. Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring. Heliyon. 2021 Apr 13;7(4):e06730. doi: 10.1016/j.heliyon.2021.e06730. eCollection 2021 Apr. PMID: 33912711; PMCID: PMC8066425.
Copy Download .nbib Format: NLM
Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO).

Geburtshilfe und Frauenheilkunde

Pross T, Karsten MM, Blohmer JU, Speiser D.
PMID: 34531609
Geburtshilfe Frauenheilkd. 2021 Sep;81(9):1031-1038. doi: 10.1055/a-1395-7715. Epub 2021 Sep 13.

No abstract available.

Cite
Pross T, Karsten MM, Blohmer JU, et al. Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO). Geburtshilfe Frauenheilkd. 2021;81(9):1031-1038doi: 10.1055/a-1395-7715.
Pross, T., Karsten, M. M., Blohmer, J. U., & Speiser, D. (2021). Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO). Geburtshilfe und Frauenheilkunde, 81(9), 1031-1038. https://doi.org/10.1055/a-1395-7715
Pross, Therese, et al. "Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO)." Geburtshilfe und Frauenheilkunde vol. 81,9 (2021): 1031-1038. doi: https://doi.org/10.1055/a-1395-7715
Pross T, Karsten MM, Blohmer JU, Speiser D. Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO). Geburtshilfe Frauenheilkd. 2021 Sep;81(9):1031-1038. doi: 10.1055/a-1395-7715. Epub 2021 Sep 13. PMID: 34531609; PMCID: PMC8437580.
Copy Download .nbib Format: NLM
Patient-Reported Outcomes and Aesthetic Results after Immediate Breast Reconstruction Using Human Acellular Dermal Matrices: Results of a Multicenter, Prospective, Observational NOGGO-AWOGyn Study.

Breast care (Basel, Switzerland)

Blohmer JU, Beier L, Faridi A, Ankel C, Krause-Bergmann B, Paepke S, Mau C, Keller M, Strittmatter HJ, Karsten MM.
PMID: 34594165
Breast Care (Basel). 2021 Aug;16(4):335-342. doi: 10.1159/000509568. Epub 2020 Sep 16.

BACKGROUND: With the increased use of acellular dermal matrices (ADMs) in implant-based breast reconstructions (IBBRs), the evaluation of patient-reported outcomes becomes more important.METHODS: Patients who underwent an immediate human ADM-assisted, submuscular IBBR were included in this noninterventional, multicenter, prospective...

Cite
Blohmer JU, Beier L, Faridi A, et al. Patient-Reported Outcomes and Aesthetic Results after Immediate Breast Reconstruction Using Human Acellular Dermal Matrices: Results of a Multicenter, Prospective, Observational NOGGO-AWOGyn Study. Breast Care (Basel). 2020;16(4):335-342doi: 10.1159/000509568.
Blohmer, J. U., Beier, L., Faridi, A., Ankel, C., Krause-Bergmann, B., Paepke, S., Mau, C., Keller, M., Strittmatter, H. J., & Karsten, M. M. (2021). Patient-Reported Outcomes and Aesthetic Results after Immediate Breast Reconstruction Using Human Acellular Dermal Matrices: Results of a Multicenter, Prospective, Observational NOGGO-AWOGyn Study. Breast care (Basel, Switzerland), 16(4), 335-342. https://doi.org/10.1159/000509568
Blohmer, Jens-Uwe, et al. "Patient-Reported Outcomes and Aesthetic Results after Immediate Breast Reconstruction Using Human Acellular Dermal Matrices: Results of a Multicenter, Prospective, Observational NOGGO-AWOGyn Study." Breast care (Basel, Switzerland) vol. 16,4 (2021): 335-342. doi: https://doi.org/10.1159/000509568
Blohmer JU, Beier L, Faridi A, Ankel C, Krause-Bergmann B, Paepke S, Mau C, Keller M, Strittmatter HJ, Karsten MM. Patient-Reported Outcomes and Aesthetic Results after Immediate Breast Reconstruction Using Human Acellular Dermal Matrices: Results of a Multicenter, Prospective, Observational NOGGO-AWOGyn Study. Breast Care (Basel). 2021 Aug;16(4):335-342. doi: 10.1159/000509568. Epub 2020 Sep 16. PMID: 34594165; PMCID: PMC8436721.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 70 entries